These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

426 related items for PubMed ID: 12097263

  • 1. Targeted expression of green fluorescent protein/tumor necrosis factor-related apoptosis-inducing ligand fusion protein from human telomerase reverse transcriptase promoter elicits antitumor activity without toxic effects on primary human hepatocytes.
    Lin T, Gu J, Zhang L, Huang X, Stephens LC, Curley SA, Fang B.
    Cancer Res; 2002 Jul 01; 62(13):3620-5. PubMed ID: 12097263
    [Abstract] [Full Text] [Related]

  • 2. Antitumor activity and bystander effects of the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene.
    Kagawa S, He C, Gu J, Koch P, Rha SJ, Roth JA, Curley SA, Stephens LC, Fang B.
    Cancer Res; 2001 Apr 15; 61(8):3330-8. PubMed ID: 11309289
    [Abstract] [Full Text] [Related]

  • 3. Suppressing orthotopic pancreatic tumor growth with a fiber-modified adenovector expressing the TRAIL gene from the human telomerase reverse transcriptase promoter.
    Jacob D, Davis J, Zhu H, Zhang L, Teraishi F, Wu S, Marini FC, Fang B.
    Clin Cancer Res; 2004 May 15; 10(10):3535-41. PubMed ID: 15161713
    [Abstract] [Full Text] [Related]

  • 4. Cisplatin enhances apoptosis induced by a tumor-selective adenovirus expressing tumor necrosis factor-related apoptosis-inducing ligand.
    Reddy RM, Tsai WS, Ziauddin MF, Zuo J, Cole GW, Maxhimer JB, Fang B, Schrump DS, Nguyen DM.
    J Thorac Cardiovasc Surg; 2004 Dec 15; 128(6):883-91. PubMed ID: 15573073
    [Abstract] [Full Text] [Related]

  • 5. Combined TRAIL and Bax gene therapy prolonged survival in mice with ovarian cancer xenograft.
    Huang X, Lin T, Gu J, Zhang L, Roth JA, Stephens LC, Yu Y, Liu J, Fang B.
    Gene Ther; 2002 Oct 15; 9(20):1379-86. PubMed ID: 12365003
    [Abstract] [Full Text] [Related]

  • 6. Long-term tumor-free survival from treatment with the GFP-TRAIL fusion gene expressed from the hTERT promoter in breast cancer cells.
    Lin T, Huang X, Gu J, Zhang L, Roth JA, Xiong M, Curley SA, Yu Y, Hunt KK, Fang B.
    Oncogene; 2002 Nov 14; 21(52):8020-8. PubMed ID: 12439752
    [Abstract] [Full Text] [Related]

  • 7. A novel single tetracycline-regulative adenoviral vector for tumor-specific Bax gene expression and cell killing in vitro and in vivo.
    Gu J, Zhang L, Huang X, Lin T, Yin M, Xu K, Ji L, Roth JA, Fang B.
    Oncogene; 2002 Jul 18; 21(31):4757-64. PubMed ID: 12101414
    [Abstract] [Full Text] [Related]

  • 8. [Killing effect of Ad.TERT-TRAIL on tumor cell lines and its mechanism].
    Tang YX, Chen Y, Gu JF, Qi R, Zou WG, Jiang LL, Liu XY.
    Ai Zheng; 2005 May 18; 24(5):536-42. PubMed ID: 15890093
    [Abstract] [Full Text] [Related]

  • 9. Tumor-specific transgene expression from the human telomerase reverse transcriptase promoter enables targeting of the therapeutic effects of the Bax gene to cancers.
    Gu J, Kagawa S, Takakura M, Kyo S, Inoue M, Roth JA, Fang B.
    Cancer Res; 2000 Oct 01; 60(19):5359-64. PubMed ID: 11034071
    [Abstract] [Full Text] [Related]

  • 10. Cancer gene therapy using a novel secretable trimeric TRAIL.
    Kim CY, Jeong M, Mushiake H, Kim BM, Kim WB, Ko JP, Kim MH, Kim M, Kim TH, Robbins PD, Billiar TR, Seol DW.
    Gene Ther; 2006 Feb 01; 13(4):330-8. PubMed ID: 16195699
    [Abstract] [Full Text] [Related]

  • 11. [The efficacy of autocatalytic casapse-3 driven by human telomerase reverse transcriptase promoter on human ovarian carcinoma].
    Song Y, Shen K, Yu JR.
    Zhonghua Yi Xue Za Zhi; 2007 Nov 06; 87(41):2919-24. PubMed ID: 18261307
    [Abstract] [Full Text] [Related]

  • 12. [Construction of autocatalytic caspase-3 driven by amplified human telomerase reverse transcriptase promoter and its enhanced efficacy of inducing apoptosis in human ovarian carcinoma].
    Song Y, Shen K, He CX.
    Zhonghua Fu Chan Ke Za Zhi; 2007 Sep 06; 42(9):617-22. PubMed ID: 17983518
    [Abstract] [Full Text] [Related]

  • 13. Enhanced apoptosis of glioma cell lines is achieved by co-delivering FasL-GFP and TRAIL with a complex Ad5 vector.
    Rubinchik S, Yu H, Woraratanadharm J, Voelkel-Johnson C, Norris JS, Dong JY.
    Cancer Gene Ther; 2003 Nov 06; 10(11):814-22. PubMed ID: 14605667
    [Abstract] [Full Text] [Related]

  • 14. Complete elimination of colorectal tumor xenograft by combined manganese superoxide dismutase with tumor necrosis factor-related apoptosis-inducing ligand gene virotherapy.
    Zhang Y, Gu J, Zhao L, He L, Qian W, Wang J, Wang Y, Qian Q, Qian C, Wu J, Liu XY.
    Cancer Res; 2006 Apr 15; 66(8):4291-8. PubMed ID: 16618754
    [Abstract] [Full Text] [Related]

  • 15. An oncolytic adenoviral vector of Smac increases antitumor activity of TRAIL against HCC in human cells and in mice.
    Pei Z, Chu L, Zou W, Zhang Z, Qiu S, Qi R, Gu J, Qian C, Liu X.
    Hepatology; 2004 May 15; 39(5):1371-81. PubMed ID: 15122766
    [Abstract] [Full Text] [Related]

  • 16. Visualization of intrathoracically disseminated solid tumors in mice with optical imaging by telomerase-specific amplification of a transferred green fluorescent protein gene.
    Umeoka T, Kawashima T, Kagawa S, Teraishi F, Taki M, Nishizaki M, Kyo S, Nagai K, Urata Y, Tanaka N, Fujiwara T.
    Cancer Res; 2004 Sep 01; 64(17):6259-65. PubMed ID: 15342413
    [Abstract] [Full Text] [Related]

  • 17. AAV-mediated TRAIL gene expression driven by hTERT promoter suppressed human hepatocellular carcinoma growth in mice.
    Zhang Y, Ma H, Zhang J, Liu S, Liu Y, Zheng D.
    Life Sci; 2008 Jun 06; 82(23-24):1154-61. PubMed ID: 18485417
    [Abstract] [Full Text] [Related]

  • 18. Adenoviral gene transfer of tumor necrosis factor-related apoptosis-inducing ligand overcomes an impaired response of hepatoma cells but causes severe apoptosis in primary human hepatocytes.
    Armeanu S, Lauer UM, Smirnow I, Schenk M, Weiss TS, Gregor M, Bitzer M.
    Cancer Res; 2003 May 15; 63(10):2369-72. PubMed ID: 12750253
    [Abstract] [Full Text] [Related]

  • 19. Potent antitumor effect of TRAIL mediated by a novel adeno-associated viral vector targeting to telomerase activity for human hepatocellular carcinoma.
    Wang Y, Huang F, Cai H, Zhong S, Liu X, Tan WS.
    J Gene Med; 2008 May 15; 10(5):518-26. PubMed ID: 18338833
    [Abstract] [Full Text] [Related]

  • 20. Cell to cell contact required for bystander effect of the TNF-related apoptosis-inducing ligand (TRAIL) gene.
    Huang X, Lin T, Gu J, Zhang L, Roth JA, Liu J, Fang B.
    Int J Oncol; 2003 Jun 15; 22(6):1241-5. PubMed ID: 12738989
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.